New combo therapy may slow severe nearsightedness in kids
NCT ID NCT07406399
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether combining low-dose atropine eye drops with special soft contact lenses can slow the progression of high myopia (severe nearsightedness) in children aged 6-12. 120 children were split into three groups: one got the combo therapy, one got atropine alone with glasses, and one got a lower dose of atropine with glasses. The main goal was to measure changes in eye length and prescription over 2 years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tongren Eye Center, Beijing Tongren Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden heart risks in Wilson's disease: a new scan could spot them early
- Can a new formula save more children from severe malnutrition?
- Can a new sedative combo make Children's gastroscopy safer?
- Could a buzzing device make childhood shots painless?
- Could a WhatsApp program give kids healthier smiles? a trial puts it to the test.
- Can a better numbing gel make dental shots less scary for kids?